Role of valproic acid and allopurinol in neuroprotection after cardiac surgery on Bangladeshi patients


  • Omar Sadeque Khan Department of Cardiac Surgery, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • Rezwannul Hoque Department of Cardiac Surgery, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • Mostafizur Rahman Department of Cardiac Surgery, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • Nasif Imtiaz Department of Cardiac Anaesthesia, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh



Per-oral perioperative, Sodium valproic acid, Allopurinol, On-pump cardiac


Background: Neurological complications are very much common after cardiac surgery in postoperative setting in Bangladesh. However, we are dealing these complications in our day-to-day practice and it costs money, longer hospital stays and admissions to rehabilitation facilities. The aim of the study was to evaluate the effectiveness of sodium valproic acid and allopurinol in preventing neurological injury following cardiac surgery with cardiopulmonary bypass.

Methods: This cross-sectional study was conducted by the department of cardiac surgery, Bangabandhu Sheikh Mujib medical university (BSMMU), Dhaka, Bangladesh from January 2019 to June 2021. Total 70 patients were included and divided into two groups (36 patients with sodium valproic acid and allopurinol in group A and 34 patients without sodium valproic acid and allopurinol in group B). 10 patients were dropped out. As these two drugs were FDA approved was used per-orally for 5 perioperative days (2 days prior surgery, 1 day in operation day, 2 days postoperatively). Collected data were entered, checked and edited (to remove the outliers) with the help of the statistical package for social sciences (SPSS) software, version 26 and analyzed.

Results: The intervention group (group A) had maximum survival rate (no mortality) less ICU stay, less hospital stay, early intubation, no neurological injury (p<0.05). On the contrary group B (no intervention) had 6 mortalities, several mild to moderate neurological injury, more ICU and hospital stay and morbidity.

Conclusions: Sodium valproic acid and allopurinol gives neuroprotection in on-pump cardiac surgical patients. So, these two medicines can be prescribed prophylactically on individual basis.


Roach GW, Kanchuger M, Mangano CM. Adverse cerebral outcomes after coronary bypass surgery. Multicenter study of perioperative ischemia research group and the ischemia research and education foundation investigators. N E Med J. 1996;335(25):1857-63.

Redmond JM, Gillinov AM, Zehr KJ. Glutamate excitotoxicity: a mechanism of neurologic injury associated with hypothermic circulatory arrest. J Thorac Cardiovascul Surg. 1994;107(1):776-86.

Baumgartner WA. Neurocognitive changes after coronary bypss surgery. J Am Heart Assoc. 2007;116(16):1879-81.

Olney J. Neurotoxicity of excitatory amino acids as a tool in neurobiology. J Neurosci. 1978;65(1):95.

Endres M, Wang ZQ, Namura S, Wacher C, Moskowitz MA. Ischemic brain injury is mediated by the activation of poly (ADP-ribose) polymerase. J Cereb Blood Flow Metabol. 1997;17(11):1143-51.

Mandir AS, Poitras MF, Berliner AR. NMDA but not non-NMDA excitotoxicity is mediated by Poly (ADP-ribose) polymerase. J Neurosci. 2000;20(21):8005-11.

Pieper AA, Blackshaw S, Clements EE. Poly (ADP ribosylation) basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission. Intens Care Ann Update. 2000;97(16):1845-50.

Robert SB. Brain protection in cardiac surgery. 1st ed. London: Springer; 2011.

Robert RC, Susan AM, James EG, Deborah GH, Norwood J, William G, et al. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Am Acad Pediatr J. 2000;108(1):61-70.

Pickel Z, Williams AM, Alam B, Cindy H. Histone deacetylase inhibitors: a novel strategy for neuroprotection and cardioprotection following ischemia/reperfusion injury. J Am Heart Assoc. 2020;9(11):234-9.

Pramod KD, Sara AO, Zhang M, Raymond JG, Pati S, Jing Z, et al. Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. Pub Lib Sci One. 2010;5(6):53-60.

Redmond JM, Greene PS, Goldsborough MA. Neurologic injury in cardiac surgical patients with a history of stroke. Ann Thorac Surg. 1996;61(1):42-7.

Rodríguez FJ, Fernández DC, Lopez MA, Lopez RM, Balada CR, Alcantara HS, et al. Neuroprotection with hypothermia and allopurinol in an animal model of hypoxic-ischemic injury: is it a gender question? Pub Lib Sci One. 2017;25(6):131-9.

Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem. 2004;89(3):1358-67.

Sotaniemi KA. Brain damage and neurological outcome after open-heart surgery. J Neurol Neurosurg Psychiat. 1980;43(2):127-35.






Original Research Articles